Fubotv earnings beat by $0.10, revenue topped estimates
Painreform Ltd (PRFX) stock has plummeted to a 52-week low, trading at $1.72, as the company faces a challenging period marked by a significant downturn in its market valuation. With a market capitalization of just $1.56 million and an EBITDA of -$17.81 million, the company's financial health score on InvestingPro is rated as WEAK. Over the past year, PRFX has seen its stock value erode dramatically, with a 1-year change showing a staggering decrease of -95.12%. This sharp decline has alarmed investors and analysts alike, as the company grapples with market dynamics and internal challenges, including a concerning current ratio of 0.61 and negative free cash flow yield of -7%. According to InvestingPro analysis, while the RSI suggests the stock is in oversold territory, the company is quickly burning through cash. The 52-week low serves as a critical indicator of the stock's performance, reflecting investor sentiment and the company's ongoing efforts to stabilize and potentially reverse the downward trend. [Unlock 12 more exclusive InvestingPro Tips for PRFX]
In other recent news, PainReform Ltd. has announced a strategic shift towards the clean energy sector with the acquisition of DeepSolar, an AI-driven solar analytics platform. This acquisition is expected to generate significant revenue and enhance long-term shareholder value through DeepSolar's scalable SaaS platform. PainReform plans to explore strategic partnerships with utility companies, solar technology providers, and smart grid operators. Financially, PainReform reported an increase in research and development expenses to approximately $11.7 million for the year ended December 31, 2024, up from $6.0 million the previous year, primarily due to clinical trial and manufacturing costs. General and administrative expenses decreased to $3.0 million from $3.6 million, attributed to lower insurance costs and share-based compensation expenses. The company experienced a net loss of approximately $14.6 million for the year, an increase from a net loss of $9.3 million in the prior year. A recent $0.9 million capital raise and the DeepSolar acquisition have bolstered shareholder equity, believed to now exceed Nasdaq's minimum requirement of $2.5 million. As of December 31, 2024, PainReform had a positive working capital of approximately $2.0 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.